Back2School - CBT Intervention for School Absenteeism (B2S)

March 14, 2023 updated by: University of Aarhus

Cognitive Behavioral Therapy Intervention for School Absenteeism: a Randomized Controlled Trial

The main objective of this study is to examine the efficacy of a new psychological intervention, called Back2School, in helping youths with problematic school absenteeism to return to school. Furthermore, the study will examine how well this program fares against the treatment or interventions that are usually given to youths with school absenteeism (treatment as usual or TAU).

Based on previous studies we hypothesize that the Back2School intervention will be better at improving levels of school attendance as compared with treatment as usual (TAU).

Study Overview

Detailed Description

Primary objective The main objective of this study is to examine the efficacy on school attendance and wellbeing of a modular trans-diagnostic CBT intervention for youths with problematic school absenteeism in a randomized controlled trial. Based on previous studies we hypothesize that the B2S intervention will show a significant difference in impact for school attendance, in favor of Back2School intervention as compared with TAU

Trial design The study is a randomized controlled superiority trial (RCT) that compares a modular trans-diagnostic CBT intervention (Back2School), treating school absenteeism in youths aged 7-17 years with treatment as usual (TAU). The design will follow a two (Back2School and TAU) by four (Time: pre, post, 3-month, and 1-year assessment) mixed between-within design.

The study is a collaboration project between Aarhus University and Aarhus Municipality, Denmark. The setting for both the B2S and TAU interventions are within Aarhus municipality. The Back2School intervention is organized and conducted by the University Clinic, at Aarhus University. Treatment as usual interventions are organized and conducted by Aarhus Municipality.

There are considerable negative long-term consequences related to youths with school absenteeism. If the B2S intervention proves to be effective in reducing school absenteeism, it could be implemented in other municipalities in Denmark, and help to systematically treat and help youths with school absenteeism. This could possibly reduce both personal and societal costs significantly

Study Type

Interventional

Enrollment (Actual)

155

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Århus, Denmark, 8000
        • Aarhus University, Department of Psychology and Behavioural Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

7 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Youths are enrolled in a public school within the municipality of Aarhus.
  • Aged 7-18 years and in 0-9th grade (excluding second semester of the 9th grade).
  • Report more than 10% absenteeism during the last 3 months of school (excluding legal absence, e.g. permitted extra holidays).
  • The youth and at least one of the two parents understand and speak Danish sufficiently to participate in treatment and complete questionnaires.
  • At least one of the parents is motivated for working on increasing the youths' school attendance.
  • The participating families are willing to participate in assessment, intervention procedures, and acceptance of random assignment to intervention.
  • Written informed consent from the holders of the parental rights and responsibilities (usually both parents).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Back2School Condition

The Back2School condition is a Modular Trans-Diagnostic Cognitive Behavioral Therapy (MTCBT) treating school absenteeism in youths.

The MTCBT intervention consist of 10 sessions and 4 school meetings, conducted over a period of 4 months.

Modular Trans-diagnostic Cognitive Behavioral Therapy treating school absenteeism in youths
Other Names:
  • B2S
Active Comparator: Treatment As Usual Condition

The Treatment As Usual condition (TAU) consist of an array of interventions that the municipality is required to give youths presenting school absenteeism.

The TAU condition will last for 4 months.

Aarhus municipality's treatment as usual for youths presenting school absenteeism
Other Names:
  • TAU

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in School Attendance - Registry data
Time Frame: Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
Aarhus Municipality's registry data of the youths' school attendance
Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
Change in School Attendance - Self-reported data
Time Frame: Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
Self-reported school attendance in the previous two weeks, reported by parents.
Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Strength and Difficulties Questionnaire (SDQ)
Time Frame: Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up

The SDQ measures psychopathology in youths (3-16 years). There is a SDQ version for youths (SDQ), parents (SDQ-P), and teachers (SDQ-T). The different versions consist of the same items, and are scored identically.

Total of 25 items, rated on a 3-point scale (0-2), divided into 5 sub-scales consisting of 5 items.

Sub-scales: Emotional symptoms, Conduct problems, Hyperactivity/inattention, Peer relationships problems, Pro-social behavior

For each sub-scale, minimum score is 0 and maximum total score is 10 The total score is computed by summing up the sub-scales, with the exception of the "pro-social behavior" sub-scale. Minimum total score is 0, and maximum total score is 40.

The extended version of the SDQ includes an impact scale with additional 8 items, regarding child distress and interference. The Impact scale is scored on a 4-point scale (0-3). The impact scale is summed up by counting only scores of 2 or 3. Minimum score 0, and maximum score 24.

Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
The Spence Children's Anxiety Scale (SCAS)
Time Frame: Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up

Self-report rating scale assessing youths symptoms of anxiety, rated by youths (SCAS) and parents (SCAS-P).

Total of 38 items, rated on a 4-point scale (0-3), divided into 6 sub-scales. The SCAS includes 6 positive filler items not included in the computation of sub-scores or total score.

Sub-scales: Social Phobia (6 items), Panic disorder and agoraphobia (9 items), Generalized anxiety disorder (6 items, range 0-18), Obsessive-compulsive disorder (6 items, range 0-18), separation anxiety disorder (6 items, range 0-18), Fear of physical injury (5 items, , range 0-15).

Minimum total score is 0, and maximum total score is 114.

The SCAS-P is identical to the SCAS in form an scoring, but does not include the 6 positive filler items.

Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
The Mood and Feelings Questionnaire (MFQ)
Time Frame: Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up

Covers a broad range of cognitive and vegetative symptoms of depression in youths. There is both a youth (MFQ) and parent (MFQ-P) version of the MFQ.

The MFQ consistTotal of 33 items, rated on a 3-point scale (0-2). The MFQ-P consist of 34 items.

Both the scores for MFQ and MFQ-P are computed by summing up all items. Higher scores indicating more sever depressive symptoms.

Minimum MFQ score is 0, maximum score is 66. Minimum MFQ-P score is 0, maximum score is 68.

Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
The Child Health Utility 9D Index (CHU-9D)
Time Frame: Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up

Designed to determine how health affect youths's lives, rated by youths.

Consist of 9 items, rated on a 5-point scale.

Each item is related to a dimension to how the youths are feeling worried, sad, pain, tired, annoyed, schoolwork/ homework, sleep, daily routine, and participating in activities.

Higher scores for each item is related to a higher perceived difficulty related to a dimension.

Each dimension/item has a minimum score of 1, and a maximum score of 5.

Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
The Self-efficacy Questionnaire for School Situations (SEQ-SS)
Time Frame: Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up

Measures self-efficacy expectations to different school situations, rated by youths.

Consist of 12 items, rated on a 5-point scale (1-5), and divided into 2 sub-scales both consisting of 6 items.

Minimum SEQ-SS score is 12, maximum score is 60.

Higher scores reflect greater self-efficacy expectations.

Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
Self-Efficacy Questionnaire for Responding to School Attendance Problems (SEQ-RSAP)
Time Frame: Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up

Measures parents self-efficacy expectations to different school situations, rated by parents.

Consist of 13 items, rated on a 4-point scale (1-4).

Minimum score is 13, and maximum score is 52.

Higher scores reflect greater self-efficacy expectations in parents ability to help their child in different school situations.

Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up
The Family Assessment Device (FAD)
Time Frame: Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up

Assess different dimensions of family function, rated by youths (12 years and older) and parents.

Only the sub-scale regarding General Function is used in this study. The sub-scale consist of 12 items, rated on a 4 point-scale (1-4).

The FAD is scored by calculating the mean scores of all items. Higher means are related to a more unhealthy or non-functional family function.

Baseline, post-treatment (4-months), 3-months follow-up, 12-months follow-up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Experience of Service Questionnaire (ESQ)
Time Frame: Post-treatment (4-months), 3-months follow-up.

Assess the satisfaction with the treatment, rated by youths and parents.

The treatment satisfaction for the youths consist of 7 items rated on a 3 point-scale (0-2), with 1 open question.

Treatment satisfaction for parents is assessed using 10 items, rated on a 3-point-scale (0-2), with 3 open questions.

Higher scores is associated with

Post-treatment (4-months), 3-months follow-up.
Collaboration with the school
Time Frame: Post-treatment (4-months), 3-months follow-up, 12-months follow-up

Assess the collaboration between the family and the school/teacher.

Consist of 3 items rated on a 4-point scale (1-4). Higher scores are related to a good relationship and collaboration with the school.

Both parents and teachers respond to this questionnaire.

Post-treatment (4-months), 3-months follow-up, 12-months follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mikael Thastum, Professor, Aarhus University, Department of Psychology and Behavioural Sciences
  • Study Director: Johanne L Jeppesen, PhD, Aarhus University, Department of Psychology and Behavioural Sciences
  • Study Director: Daniel B Johnsen, PhD Fellow, Aarhus University, Department of Psychology and Behavioural Sciences

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 25, 2017

Primary Completion (Actual)

December 1, 2020

Study Completion (Actual)

December 1, 2020

Study Registration Dates

First Submitted

February 15, 2018

First Submitted That Met QC Criteria

March 2, 2018

First Posted (Actual)

March 9, 2018

Study Record Updates

Last Update Posted (Actual)

March 15, 2023

Last Update Submitted That Met QC Criteria

March 14, 2023

Last Verified

April 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SPONSoR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depressive Symptoms

3
Subscribe